Substance
ID:182407
Names and Identifiers
IUPAC name
(2S)-N-[(2S)-5-carbamimidamido-1-[(2S)-2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-[(2R)-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamide
Synonyms
[D-Trp6]-Luteinizing hormone releasing hormone[D-Trp6]-LH-RH
IUPAC Traditional name
triptorelin
Properties
Safety Information
German water hazard class
3
Risk Statements
60
GHS Hazard statements
H360
GHS Pictograms
Respiratory sensitization, category 1
Germ cell mutagenicity, categories 1A,1B,2
Carcinogenicity, categories 1A,1B,2
Reproductive toxicity, categories 1A,1B,2
Specific Target Organ Toxicity – Single exposure, categories 1,2
Specific Target Organ Toxicity – Repeated exposure, categories 1,2
Aspiration Hazard, category 1
European Hazard Symbols
Toxic (T)GHS Precautionary statements
P201-P308+P313
GHS Signal Word
Danger
Personal Protective Equipment
Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
Storage Temperature
-20°C
Safety Statements
53-22-36/37/39-45
Product Information
Purity
≥97% (HPLC)
Physical Property
Apperance
powder
Pharmacology Properties
Gene Information
human ... GNRH1(2796)
Molecule Details
Amino Acid Sequence
Glp-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2
Biochem/physiol Actions
Potent LH-RH agonist with enhanced biological activity due to its slower rate of degradation. Like [D-Lys6]-LH-RH, the D-Trp6 analog has been shown to be effective against cancers expressing the LH-RH receptor. However, unlike the D-Lys6 analog, it is generally used in the unconjugated form.
Glp-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2
Biochem/physiol Actions
Potent LH-RH agonist with enhanced biological activity due to its slower rate of degradation. Like [D-Lys6]-LH-RH, the D-Trp6 analog has been shown to be effective against cancers expressing the LH-RH receptor. However, unlike the D-Lys6 analog, it is generally used in the unconjugated form.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data